These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23121577)

  • 41. Communication of false-positive tests--can it be improved?
    Ghosh AK; Ghosh K
    Am J Med; 2003 Jun; 114(9):768. PubMed ID: 12829206
    [No Abstract]   [Full Text] [Related]  

  • 42. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
    Duijm LE; Guit GL; Zaat JO
    Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mammography screening: how far is too far?
    Osmun WE; Copeland J; Boisvert L
    Rural Remote Health; 2013; 13(1):2149. PubMed ID: 23406261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. National Health Service breast screening programme results for 1991-2.
    Chamberlain J; Moss SM; Kirkpatrick AE; Michell M; Johns L
    BMJ; 1993 Aug; 307(6900):353-6. PubMed ID: 8374416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Who evaluates public health programmes? A review of the NHS Breast Screening Programme.
    Jørgensen KJ; Gøtzsche PC
    J R Soc Med; 2010 Jan; 103(1):14-20. PubMed ID: 20056665
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of Screening Mammography to Detect Occult Malignancy in Autologous Breast Reconstructions: A 15-year Experience.
    Noroozian M; Carlson LW; Savage JL; Jeffries DO; Joe AI; Neal CH; Patterson SK; Hadjiiski LM; Helvie MA
    Radiology; 2018 Oct; 289(1):39-48. PubMed ID: 30129903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis.
    Chapman S; McLeod K; Wakefield M; Holding S
    Med J Aust; 2005 Sep; 183(5):247-50. PubMed ID: 16138798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting the cumulative risk of false-positive mammograms.
    Christiansen CL; Wang F; Barton MB; Kreuter W; Elmore JG; Gelfand AE; Fletcher SW
    J Natl Cancer Inst; 2000 Oct; 92(20):1657-66. PubMed ID: 11036111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures.
    Brown ML; Houn F; Sickles EA; Kessler LG
    AJR Am J Roentgenol; 1995 Dec; 165(6):1373-7. PubMed ID: 7484568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of individual radiographers on rates of attendance to breast screening: a 7-year retrospective study.
    Savaridas SL; Brook J; Codde JP; Bulsara M; Wylie E
    Clin Radiol; 2018 Apr; 73(4):413.e7-413.e13. PubMed ID: 29273227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Routine mammography screening increases except among minorities and the elderly.
    Oncology (Williston Park); 2002 Jan; 16(1):63, 123. PubMed ID: 11831611
    [No Abstract]   [Full Text] [Related]  

  • 53. Double reporting of screening mammograms.
    Matson M; Hibbert J; Field S
    Clin Radiol; 1997 Jul; 52(7):567. PubMed ID: 9240718
    [No Abstract]   [Full Text] [Related]  

  • 54. Mammographic screening in Italy.
    Franceschi S; Geddes M
    Lancet; 1991 Nov; 338(8779):1402-3. PubMed ID: 1682768
    [No Abstract]   [Full Text] [Related]  

  • 55. Can computer-aided detection with double reading of screening mammograms help decrease the false-negative rate? Initial experience.
    Destounis SV; DiNitto P; Logan-Young W; Bonaccio E; Zuley ML; Willison KM
    Radiology; 2004 Aug; 232(2):578-84. PubMed ID: 15229350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program.
    Roman M; Skaane P; Hofvind S
    Eur J Radiol; 2014 Sep; 83(9):1639-44. PubMed ID: 24972452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High Participation Rate in Mammography Screening: Experience from Croatia.
    Puharić Z; Žulec M; Ceronja I; Parun AŠ
    Cent Eur J Public Health; 2017 Dec; 25(4):303-306. PubMed ID: 29346854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreasing women's anxieties after abnormal mammograms: a controlled trial.
    Barton MB; Morley DS; Moore S; Allen JD; Kleinman KP; Emmons KM; Fletcher SW
    J Natl Cancer Inst; 2004 Apr; 96(7):529-38. PubMed ID: 15069115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Texas Breast Screening Project: Part II. Demographics, risk profiles, and health practices of participants.
    Vogel VG; Bondy M; Halabi S; Lord J; Laville EA
    South Med J; 1993 Apr; 86(4):391-6. PubMed ID: 8465214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time trends in breast cancer screening rates in the OECD countries.
    Saika K; Sobue T
    Jpn J Clin Oncol; 2011 Apr; 41(4):591-2. PubMed ID: 21447696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.